SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DNDN - Dendreon Corp. -- Ignore unavailable to you. Want to Upgrade?


To: brk who wrote (76)11/7/2000 4:33:28 PM
From: Elmer  Read Replies (1) | Respond to of 751
 
They look confident that this stuff is going to work. Because the Mylovenge trial is open blind, they know how that science is going. Keep your fingers crossed. If the science works, figure our first stop is $100. If it platforms to other forms of cancer, figure it's worth $1,000 per share. Lots of "ifs."